XML 39 R21.htm IDEA: XBRL DOCUMENT
v3.19.1

Discontinued Operations | 12 Months Ended
--- | ---
Dec. 31, 2018
Discontinued Operations and Disposal Groups [Abstract] |
Discontinued Operations | Discontinued Operations PCT Segment In May 2017, the Company sold its remaining 80.1% membership interest in PCT to Hitachi pursuant to the 2017 Hitachi Transaction (see Note 3). The aggregate purchase price to the Company consisted of (i) $75.0 million in cash, (ii) $4.4 million, representing additional consideration based on PCT’s cash and outstanding indebtedness as of the closing date, and (iii) a potential future milestone payment of $5.0 million if PCT had achieved $125 million in cumulative revenue (excluding clinical service reimbursables) for the period from January 1, 2017 through December 31, 2018. The Company had determined that the fair value of the milestone payment as of the closing date was zero and has since confirmed as of December 31, 2018 that the Milestone was not achieved. The Company recognized the following gain on the date of sale of its 80.1% interest in PCT (in thousands):
Fair value of consideration received | $ | 79,425 |
Transaction and retention costs | (6,919 | )
Carrying value of segment non-controlling interest | 3,687 |
| $ | 76,193 |
Less carrying amount of assets and liabilities sold: |
Cash | $ | 6,727 |
Accounts receivable | 3,702 |
Deferred costs | 4,685 |
Prepaid expenses and other current assets | 743 |
Property, plant and equipment, net | 14,900 |
Goodwill | 7,013 |
Intangibles, net | 2,090 |
Other assets | 215 |
Accounts payable | (2,278 | )
Accrued liabilities | (2,927 | )
Due from Caladrius | 450 |
Unearned revenues | (10,529 | )
Notes payable | (342 | )
| $ | 24,449 |
Gain on sale of PCT | $ | 51,744 |
The operations and cash flows of the PCT Segment were eliminated from ongoing operations with the sale of the Company's PCT Interest. The operating results of the PCT Segment for the year ended December 31, 2017 were as follows (in thousands):
| 2017
Revenue | $ | 16,039 |
Cost of revenues | (15,321 | )
Research and development | (257 | )
Selling, general, and administrative | (3,251 | )
Other expense | (14 | )
Provision for income taxes | (10,541 | )
Gain on sale of segment | 51,744 |
Income from discontinued operations | $ | 38,399 |

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI http://asc.fasb.org/topic&trid=2155823 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -URI http://asc.fasb.org/subtopic&trid=2122178 + Details
Name: | us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration